Skip to content
Clinical Trials – home
Uppsala Universitet
Sponsor

Uppsala Universitet

Sweden P. O. Box 256, 751 05 Uppsala, Sweden

About the sponsor

Clinical research includes relapsed or refractory CD20+ diffuse large B-cell lymphoma, mantle cell lymphoma, and indolent lymphoma, with interest in B-cell lymphoma treatment and cellular immunotherapy.

  • CD20+ diffuse large B-cell lymphoma
  • mantle cell lymphoma
  • indolent lymphoma
  • CAR T-cell therapy

The oncology portfolio reflects work in advanced lymphoid cancers and immune-based treatment strategies.

About Specializations

Uppsala Universitet runs clinical trials in conditions such as Urinary tract infection, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin Sulfate
  • Sponsor:Uppsala Universitet
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Betamethasone Sodium Phosphate
  • Sponsor:Uppsala Universitet
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Metformin
  • Sponsor:Uppsala Universitet

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.